{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:41:10Z","timestamp":1790642470103,"version":"4.1.0"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T00:00:00Z","timestamp":1495065600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Grant-in-Aid for Scientific Research (C)","award":["22590351"],"award-info":[{"award-number":["22590351"]}]},{"name":"Grant-in-Aid for Scientific Research (C)","award":["15K08435"],"award-info":[{"award-number":["15K08435"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0177934","type":"journal-article","created":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T15:45:14Z","timestamp":1495727114000},"page":"e0177934","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Beneficial effect of combined treatment with octreotide and pasireotide in PCK rats, an orthologous model of human autosomal recessive polycystic kidney disease"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5112-7923","authenticated-orcid":true,"given":"Masanori","family":"Kugita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Nishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamio","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Yuzawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Horie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Higashihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2014-9411","authenticated-orcid":true,"given":"Shizuko","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,5,18]]},"reference":[{"key":"ref1","article-title":"Prevalence of autosomal dominant polycystic kidney disease in the European Union","volume":"19","author":"CJ Willey","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nrneph.2011.109","article-title":"Why kidneys fail in autosomal dominant polycystic kidney disease","volume":"7","author":"JJ Grantham","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00467-010-1656-1","article-title":"Diagnosis and management of childhood polycystic kidney disease","volume":"26","author":"WE Sweeney Jr.","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s00247-008-1064-x","article-title":"Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis (ARPKD\/CHF)","volume":"39","author":"B Turkbey","year":"2009","journal-title":"Pediatr Radiol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1523-1755.2003.00755.x","article-title":"Renal activation of extracellular signal-regulated kinase in rats with autosomal-dominant polycystic kidney disease","volume":"63","author":"S Nagao","year":"2003","journal-title":"Kidney Int"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1046\/j.1523-1755.2003.00023.x","article-title":"Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys","volume":"63","author":"T Yamaguchi","year":"2003","journal-title":"Kidney Int"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/nm935","article-title":"Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist","volume":"9","author":"VH Gattone 2nd","year":"2003","journal-title":"Nat Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1681\/ASN.2004121090","article-title":"Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat","volume":"16","author":"X Wang","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"VE Torres","year":"2012","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1053\/j.gastro.2006.12.039","article-title":"Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3',5'-cyclic monophosphate","volume":"132","author":"TV Masyuk","year":"2007","journal-title":"Gastroenterology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/hep.26140","article-title":"Pasireotide is more effective than octreotide in reducing hepatorenal cystogenesis in rodents with polycystic kidney and liver diseases","volume":"58","author":"TV Masyuk","year":"2013","journal-title":"Hepatology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/S0140-6736(13)61407-5","article-title":"Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial","volume":"382","author":"A Caroli","year":"2013","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1681\/ASN.2006030251","article-title":"Increased water intake decreases progression of polycystic kidney disease in the PCK rat","volume":"17","author":"S Nagao","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.mce.2007.09.006","article-title":"Pasireotide (SOM230): development, mechanism of action and potential applications","volume":"286","author":"HA Schmid","year":"2008","journal-title":"Mol Cell Endocrinol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1523-1755.2005.00395.x","article-title":"Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease","volume":"68","author":"P Ruggenenti","year":"2005","journal-title":"Kidney Int"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"783","DOI":"10.2215\/CJN.05380709","article-title":"Reducing polycystic liver volume in ADPKD: effects of somatostatin analogue octreotide","volume":"5","author":"A Caroli","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1681\/ASN.2009121291","article-title":"Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease","volume":"21","author":"MC Hogan","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1093\/ndt\/gfs152","article-title":"Somatostatin analog therapy for severe polycystic liver disease: results after 2 years","volume":"27","author":"MC Hogan","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/MJT.0b013e31824c3eb4","article-title":"An open-label dose-escalation study of once-daily and twice-daily pasireotide in healthy volunteers: safety, tolerability, and effects on glucose, insulin, and glucagon levels","volume":"21","author":"M Shenouda","year":"2014","journal-title":"Am J Ther"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1530\/JOE-11-0224","article-title":"Effects of somatostatin analogs on glucose homeostasis in rats","volume":"212","author":"HA Schmid","year":"2012","journal-title":"J Endocrinol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/ng833","article-title":"The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein","volume":"30","author":"CJ Ward","year":"2002","journal-title":"Nat Genet"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0002-9440(10)64116-8","article-title":"Polycystic kidney rat is a novel animal model of Caroli's disease associated with congenital hepatic fibrosis","volume":"158","author":"T Sanzen","year":"2001","journal-title":"Am J Pathol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e81480","DOI":"10.1371\/journal.pone.0081480","article-title":"Telmisartan ameliorates fibrocystic liver disease in an orthologous rat model of human autosomal recessive polycystic kidney disease","volume":"8","author":"D Yoshihara","year":"2013","journal-title":"PLoS One"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"F465","DOI":"10.1152\/ajprenal.00460.2010","article-title":"PPAR-gamma agonist ameliorates kidney and liver disease in an orthologous rat model of human autosomal recessive polycystic kidney disease","volume":"300","author":"D Yoshihara","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1634\/theoncologist.2011-0458","article-title":"Antitumor effects of somatostatin analogs in neuroendocrine tumors","volume":"17","author":"L Sideris","year":"2012","journal-title":"Oncologist"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1111\/j.1523-1755.2004.00952.x","article-title":"Epidermal growth factor receptor tyrosine kinase inhibition is not protective in PCK rats","volume":"66","author":"VE Torres","year":"2004","journal-title":"Kidney Int"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.tcb.2010.03.004","article-title":"The regulation of energy metabolism and the IGF-1\/mTOR pathways by the p53 protein","volume":"20","author":"Z Feng","year":"2010","journal-title":"Trends Cell Biol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3892\/mmr.2013.1588","article-title":"Rosiglitazone inhibits insulin-like growth factor\u20111-induced polycystic kidney disease cell growth and p70S6 kinase activation","volume":"8","author":"C Liu","year":"2013","journal-title":"Mol Med Rep"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1681\/ASN.V371378","article-title":"Growth factor gene expression in kidney of murine polycystic kidney disease","volume":"3","author":"T Nakamura","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1210\/en.2002-220219","article-title":"SOM230: a new somatostatin peptidomimetic with potent inhibitory effects on the growth hormone\/insulin-like growth factor-I axis in rats, primates, and dogs","volume":"143","author":"G Weckbecker","year":"2002","journal-title":"Endocrinology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0177934","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T15:06:09Z","timestamp":1692803169000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0177934"}},"subtitle":[],"editor":[{"given":"Giuseppe","family":"Remuzzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,5,18]]},"references-count":30,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,5,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0177934","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,18]]}}}